EBS - AstraZeneca taps Emergent Biosolutions for COVID-19 vaccine production June, 11 2020 04:47 PM Emergent Biosolutions Inc. AstraZeneca (NYSE:AZN) will work with Emergent Biosolutions (NYSE:EBS) to help produce the 300M doses of ADZ1222 that AZN has pledged to the U.S.More news on: AstraZeneca PLC, Emergent BioSolutions Inc., Healthcare stocks news, Read more ...